{
  "paper_metadata": {
    "pmid": "37991089",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the BRCA2 variant c.1813delA, p.Ile605TyrfsTer9, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1813delA",
      "protein_notation": "p.Ile605TyrfsTer9",
      "genomic_position": null,
      "clinical_significance": "unknown",
      "patients": {
        "count": 3,
        "demographics": "44-year-old female patient, mother, and sister",
        "phenotype": "triple-negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 2,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 44,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "triple-negative breast cancer",
          "evidence_sentence": "The patient was diagnosed with breast cancer with a genetic variant of BRCA2 segregated in the family."
        },
        {
          "individual_id": "Mother",
          "age_at_evaluation": 53,
          "age_at_onset": null,
          "age_at_diagnosis": 53,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "human epidermal growth factor receptor-positive breast cancer",
          "evidence_sentence": "The patient\u2019s mother developed human epidermal growth factor receptor-positive breast cancer in the left breast at the age of 53 years."
        },
        {
          "individual_id": "Sister",
          "age_at_evaluation": 39,
          "age_at_onset": null,
          "age_at_diagnosis": 39,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "preventive double mastectomy",
          "evidence_sentence": "The patient\u2019s sister had the same genetic variant detected during the molecular testing of BRCA1 and BRCA2 genes at the age of 39 years and underwent preventive double mastectomy at the age of 42 years."
        }
      ],
      "functional_data": {
        "summary": "No functional data provided in the paper.",
        "assays": []
      },
      "segregation_data": "Yes, the variant segregates with disease in the family.",
      "population_frequency": null,
      "evidence_level": "unknown",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The patient did not have pathogenic genetic variants but had relatives with a genetic mutation in BRCA2.",
      "key_quotes": [
        "The patient was diagnosed with breast cancer with a genetic variant of BRCA2 segregated in the family.",
        "The patient\u2019s mother developed human epidermal growth factor receptor-positive breast cancer in the left breast at the age of 53 years.",
        "The patient\u2019s sister had the same genetic variant detected during the molecular testing of BRCA1 and BRCA2 genes at the age of 39 years and underwent preventive double mastectomy at the age of 42 years."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the BRCA2 variant was extracted from the main text."
  }
}